Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality www.ahrq.gov
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

19. Treatments Show Promise in Reducing Autism-related Behaviors

Director's Update

Text version of slide presentation from a National Advisory Council meeting.

Text Description is below the image.

  • New comparative effectiveness review from Effective Health Care (EHC) Program:
    • Autism spectrum disorders (ASDs) affect nearly 1 percent of children in the United States.
    • Some medications can reduce selected behaviors in children with ASDs but have significant side effects.
    • Behavioral treatments show promise but evidence of effectiveness is limited.
    • The drug Secretin has been studied extensively and shows no effectiveness.

https://effectivehealthcare.ahrq.gov

 


Previous Slide         Contents         Next Slide


Page last reviewed August 2011
Page originally created August 2011
Internet Citation: 19. Treatments Show Promise in Reducing Autism-related Behaviors. Content last reviewed August 2011. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/events/nac/2011-04-nac/clancy/slide19.html

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care